Evidence map›Paper›PMID 30542255›Full record

ArticleFrontiers in neuroscience2018

Antiepileptic Drug of Levetiracetam Decreases Centrotemporal Spike-Associated Activation in Rolandic Epilepsy.

Qirui Zhang, Fang Yang, Zheng Hu, Qiang Xu, Boris C Bernhardt, Wei Quan, Qian Li, Zhiqiang Zhang, Guangming Lu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neuroscience, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Alterations in intra- and internetwork functional connectivity associated with levetiracetam treatment in temporal lobe epilepsy.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2020
    Article
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Qirui ZhangDepartment of Medical Imaging, Jinling Hospital, Southern Medical University, Nanjing, China.
Fang YangDepartment of Neurology, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.
Zheng HuDepartment of Neurology, Nanjing Children's Hospital, Nanjing, China.
Qiang XuDepartment of Medical Imaging, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.
Boris C BernhardtNeuroimaging of Epilepsy Laboratory, McConnell Brain Imaging Centre, Montreal Neurological Institute and Hospital, McGill University, Montreal, QC, Canada.
Wei QuanDepartment of Medical Imaging, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.
Qian LiDepartment of Neurology, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.
Zhiqiang ZhangDepartment of Medical Imaging, Jinling Hospital, Nanjing University School of Medicine, Nanjing, China.
Guangming LuDepartment of Medical Imaging, Jinling Hospital, Southern Medical University, Nanjing, China.
Nanjing General Hospital of Nanjing Military Command · CNNanjing University · CNMontreal Neurological Institute and Hospital · CANanjing Children's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective was to study the modulation effects of levetiracetam on the fMRI activation/deactivation patterns associated with centrotemporal spikes (CTS) in Rolandic epilepsy. Forty patients with Rolandic epilepsy, including levetiracetam-medicated patients (

Indexed as

antiepileptic drugscentrotemporal spikeEEG-fMRIRolandic epilepsysequential HRFs analysis

Identifiers

PMID30542255
PMCPMC6277790
OpenAlexW2902756171

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.